BofA/Merrill analyst Ryan Gee issued a double-downgrade of SciPlay to Underperform from Buy and lowered his price target on the shares to $12 from $17. The analyst notes that the company's growth has been softer-than-expected since its IPO and its upcoming Q3 results are tracking to be in-line with expectations, even though Activision Blizzard (ATVI) and Take-Two (TTWO) are headed toward upside. Gee also attributes the rating change to higher exposure to potential regulation of mobile casino games, threat of competition from legalized mobile slot games, and limited upcoming catalysts in terms of new games or new markets to generate upside.